Prognostic value of18 f-choline pet/ct in patients with metastatic castration-resistant prostate cancer treated with radium-223

12Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

We aimed to investigate the role of positron emission computed tomography (PET/CT) with18 F-choline for predicting the outcome of metastatic castration-resistant prostate cancer (mCRPC) submitted to treatment with Radium-223 (223 Ra-therapy). Clinical records of 20 mCRPC patients submitted to PET/CT with18 F-choline before223 Ra-therapy were retrospectively evaluated. The following PET-derived parameters were calculated: number of lesions, maximum and mean standardized uptake values (SUVmax, SUVmean), lean body mass corrected SUV peak (SULpeak), metabolic tumor volume (MATV), and total lesion activity (TLA). After223 Ra-therapy, all patients underwent regular follow-up until death. The predictive power of clinical and PET-derived parameters on overall survival (OS) was assessed by Kaplan–Meier analysis and the Cox proportional hazard method. All the patients showed18 F-choline-avid lesions at baseline PET/CT. Among the enrolled subjects, eleven (55%) completed all the six scheduled cycles of223 Ra-therapy; seven (35%) were responders according to imaging and biochemical parameters. Mean OS was 12.7 ± 1.4 months: by Kaplan–Meier analysis, number of lesions, PSA level and TLA were significantly correlated with OS. In multivariate Cox analysis, TLA remained the only significant predictor of survival (p = 0.003; hazard ratio = 7.6, 95% confidence interval = 1.9–29.5 months).18 F-choline PET may be useful for patients’ stratification before223 Ra-therapy. In particular, high metabolically active tumor burden (i.e., TLA) was predictive of poor outcome.

Cite

CITATION STYLE

APA

Filippi, L., Spinelli, G. P., Chiaravalloti, A., Schillaci, O., Equitani, F., & Bagni, O. (2020). Prognostic value of18 f-choline pet/ct in patients with metastatic castration-resistant prostate cancer treated with radium-223. Biomedicines, 8(12), 1–12. https://doi.org/10.3390/biomedicines8120555

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free